RxDoctor Payments Data

Anita Booth

Women's Health · Farrell, PANPI 1881677615

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $10,650 of the $11,722 with a category attached, or 90.9%. Organon accounts for 83.5% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2022 at $3,427 and has fallen 61.6% since, to $1,316 in 2025. Among women's health clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,722in general payments, 2019–2025

Across 77 payments — averaging $152.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organon$10K
  • Merck$1K
  • Pfizer$132
  • Mylan Pharmaceuticals Inc.$127
  • Agile Therapeutics, Inc.$103
  • Exact Sciences$98
  • plus $347 from 10 others

What the payments were for

  • Speaking & faculty fees$10,65091%
  • Food & beverage$1,0729%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,722 in reported general payments places this provider in the 95th percentile of 250 women's health providers in Pennsylvania.

See all women's health providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$9,892
Medicare patients
40
Services billed
303

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol16$1,235
Fluconazole18$166
Triamcinolone Acetonide24$103

Paid to pharmacies, not to this prescriber.

Other women's health in Farrell

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →